プラズマ手術の世界市場

プラズマ手術の世界市場は2030年までに9,100万米ドルに達する見込み

2024年に6,950万米ドルと推定されるプラズマ手術の世界市場は、2030年には9,100万米ドルに達し、分析期間2024-2030年のCAGRは4.6%で成長すると予測されます。本レポートで分析したセグメントの1つであるニュートラルプラズマ手術システムは、CAGR 5.1％を記録し、分析期間終了までに6,020万米ドルに達すると予測されます。プラズマアブレーションシステム分野の成長率は、分析期間中CAGR 3.8％と推定されます。

米国市場は1,890万米ドルと推定、中国はCAGR8.4％で成長予測

米国のプラズマ手術市場は、2024年には1,890万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 8.4%で推移し、2030年には予測市場規模1,900万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9％と3.6％と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界のプラズマ手術市場- 主要動向と促進要因のまとめ

現代外科診療におけるコールドプラズマとサーマルプラズマの変革的役割を探る

プラズマ手術が低侵襲治療における新たなフロンティアとなる理由とは？

プラズマ手術は、精密な組織操作、凝固、切除を行うための電離ガスプラズマの応用により、外科手術に革命をもたらしています。この分野では、コールド・アトモスフェリック・プラズマ（CAP）とサーマル・プラズマ・システムという2つの主要技術が主流です。コールドプラズマは室温で作動するため、眼科や皮膚科のようなデリケートな手術に非熱的な応用が可能です。一方、サーマル・プラズマは、整形外科や耳鼻咽喉科などの領域で凝固や切除に適した高温を発生します。これらの異なる方法は、広範な副次的損傷を与えることなく正確な組織標的を提供し、プラズマシステムを電気メス、レーザー、高周波の代替品とは一線を画しています。従来のエネルギーベースの装置とは異なり、プラズマメスやアブレーターは、かなり高度な手術精度と熱拡散の低減を実現します。例えば、扁桃摘出術やアデノイド切除術などの手術において、プラズマメスは術中出血や術後疼痛を軽減することが示されています。切開と凝固をワンステップで行えるプラズマメスは、耳鼻咽喉科、脳神経外科、婦人科、泌尿器科で普及しつつあります。さらに、バイポーラプラズマ技術の進歩により、組織のインピーダンスに基づいてエネルギー供給をリアルタイムで調節できるようになり、術中のコントロールがさらに強化されつつあります。臨床試験では、創傷治癒の改善、炎症反応の軽減、回復時間の短縮が引き続き強調されており、これらすべてがより広範な採用を促しています。

プラズマ手術システムはどこで最も市場に浸透しているか？

プラズマ手術装置の臨床導入は、幅広い外科専門分野への適合性によって推進されています。耳鼻咽喉科（ENT）は、プラズマ技術を最も早くから採用している分野の一つであり、鼻甲介縮小術、扁桃摘出術、ポリープ切除術などの手技において、プラズマ技術の低出血プロファイルが活用されています。同様に、婦人科領域では、プラズマを用いた子宮内膜焼灼術や腹腔鏡下手術が、特に熱損傷を禁忌とする患者を対象として増加しています。もう一つの高成長分野は整形外科と脊椎外科で、そこではプラズマワンドが軟部組織の効率的な除去と、敏感な神経構造周辺の正確な凝固を可能にしています。腫瘍学分野では、特に基底細胞がんや扁平上皮がんのような表在がんを対象に、腫瘍縮小のためのコールドプラズマ応用の研究が始まっています。さらに、外科手術の正確さが最も重要な神経外科では、周囲の組織の完全性を保ちながら、脳神経領域の腫瘍を切り離すためにコールドプラズマシステムが試用されています。美容外科や皮膚科の分野でも、皮膚の表面処理、にきび跡の治療、非切除式肌の若返りのためにプラズマペンの導入が急速に進んでいます。

地域別では、北米が世界のプラズマ手術市場をリードしているが、これは先進的なヘルスケア・インフラ、高い施術量、Medtronic、Smith &Nephew、Bovie Medicalといった有力企業の存在によるものです。特にドイツと英国では、耳鼻咽喉科と婦人科の使用事例が主流となっています。アジア太平洋市場は、まだ始まったばかりではあるが、手術件数の増加、民間病院の増加、皮膚科や腫瘍科における非熱プラズマ応用への関心の高まりによって、大きな可能性を示しています。韓国やインドのような国々は、コストの制約と低侵襲治療の需要から、ポータブル・ハンドヘルド・プラズマ装置の早期導入国として台頭してきています。

技術革新はプラズマベースの外科技術の将来をどのように形成しているか？

技術の進歩は、プラズマ手術応用の拡大を支える重要な柱です。最近のブレークスルーには、プラズマ装置の小型化があり、ロボット手術アームや柔軟な内視鏡プラットフォームへの統合を可能にしています。この開発は、頭蓋内、気管支、消化管腔など、到達困難な解剖学的領域へのアクセスに特に重要です。コールドプラズマシステムと光ファイバー送達モジュールの結合により、気管支内焼灼術や経鼻インターベンションなどの内腔手術において、より安全で標的を絞ったプラズマの応用が可能になりました。さらに、生物学的流体をイオン化してから組織に適用するプラズマ活性化媒体（PAM）の研究も急速に進んでおり、直接接触することなく滅菌やがん細胞のアポトーシスを行う有望なアプローチを提供しています。AIとリアルタイム分析の統合も、次世代プラズマシステムで登場し始めています。組織のフィードバックに基づいてエネルギー出力を適応させるアルゴリズムは、安全性を高め、術中の当て推量を減らしています。材料科学の面では、生体適合性のある電極コーティングと高周波変調回路の開発により、適応拡大に不可欠なアーク形成と出力密度の制御が可能になっています。

ハードウェアの革新に加え、ユーザー・インターフェースや手技テンプレートにおけるソフトウェア主導の進歩が、プラズマ装置をより外科医にやさしいものにしています。装置は現在、タッチスクリーン操作、あらかじめプログラムされた手技モード、および病院EHRとの統合を提供しています。これらの機能により、装置のトレーニングが合理化され、手技の成果が標準化され、外来でのアクセスが拡大しています。一方、機器メーカー、臨床研究者、学術機関の業界を超えた協力体制は、より強固な臨床プロトコールと安全性ベンチマークの確立に役立っており、規制当局の迅速な承認と新興国での市場参入を促進しています。

世界のプラズマ手術の台頭を促進する主なマーケットカタリストは？

世界のプラズマ手術市場の成長は、技術、臨床、規制、経済の各領域にまたがるいくつかの要因によって牽引されています。主な成長要因の1つは、ほぼすべての外科専門分野で低侵襲手術（MIS）技術が好まれるようになっていることです。外科医やヘルスケアプロバイダーは、入院時間、合併症、全体的な処置コストを削減する低外傷介入にシフトしており、プラズマ手術が特に適している分野です。プラズマシステムは、効果的な止血、視認性の向上、回復時間の短縮を可能にし、これらはすべて外科手術のスループットを加速し、患者の満足度を向上させるために不可欠です。特に米国、日本、インドでは、外来手術センター（ASC）の世界の拡大が進行中であることも追い風となっています。このような環境では、コンパクトで多機能、かつ高い安全マージンを持つ器具が求められます。さらに、老年人口が増加し、がん、子宮筋腫、鼻ポリープ、変形性関節症などの慢性疾患の有病率が上昇していることから、侵襲性が低く、かつ効果の高い外科治療に対する需要が高まっています。プラズマ手術はこのような状況において、特に従来の治療法ではリスクが高すぎたり、長時間のリハビリが必要であったりする場合に、頼りになる選択肢として台頭してきています。市場の勢いは、より有利な規制状況や償還の枠組みにも支えられています。例えば、皮膚科や耳鼻咽喉科の手術における特定のコールドプラズマアプリケーションは、米国やドイツでは現在、公的保険会社や民間保険会社によって保険適用されています。さらに、大手機器メーカーによる研究開発、製品トレーニング、世界の販売代理店ネットワークへの戦略的投資が、市場への浸透を促進しています。臨床検証のための学術機関との連携により、プラズマ技術の標準治療への迅速な統合が可能になっています。

最後に、従来の電気外科手術に伴う手術煙の危険性や組織の焦げに対する意識の高まりが、ヘルスケアシステムをより安全な代替医療へと向かわせています。プラズマ装置は、組織の壊死を抑え、手術の噴煙を最小限に抑えることで知られており、職業暴露や患者の転帰を懸念する外科医の間で好まれています。このような要因が重なり、プラズマ手術市場は精密外科技術の次の時代の中心的存在となる態勢を整えており、その普及は現在の牙城をはるかに超えるものと思われます。

セグメント

製品（ニュートラルプラズマ手術システム、プラズマアブレーションシステム、コールドプラズマサージカルシステム）、用途（アブレーション用途、切除用途、剥離用途）、最終用途（専門クリニック最終用途、外来手術センター最終用途、病院最終用途）

調査対象企業の例

• Apyx Medical Corporation
• Bovie Medical Corporation
• CONMED Corporation
• Ethicon（Johnson & Johnson）
• LivaNova plc
• Luxim
• Maquet（Getinge Group）
• Medtronic plc
• Medviatech（Otech/Airplasma）
• Olympus Corporation
• PlasmaJet（Plasma Surgical）
• Plasma Surgical, Inc.
• Renuvion（Apyx）
• Smith & Nephew plc
• Surgnova Healthcare
• US Medical Innovations（USMI）
• Ushio Inc.
• Xenco Medical
• DAMAI Tech Co., Ltd.
• Maquet（Getinge Group）
• CONMED Corporation

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Plasma Surgery Market to Reach US$91.0 Million by 2030

The global market for Plasma Surgery estimated at US$69.5 Million in the year 2024, is expected to reach US$91.0 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Neutral Plasma Surgery System, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$60.2 Million by the end of the analysis period. Growth in the Plasma Ablation System segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.9 Million While China is Forecast to Grow at 8.4% CAGR

The Plasma Surgery market in the U.S. is estimated at US$18.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$19.0 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Plasma Surgery Market - Key Trends & Drivers Summarized

Exploring the Transformational Role of Cold and Thermal Plasma in Modern Surgical Practices

What Makes Plasma Surgery an Emerging Frontier in Minimally Invasive Interventions?

Plasma surgery is revolutionizing the surgical landscape through the application of ionized gas-plasma-to perform precise tissue manipulation, coagulation, and ablation. Two principal technologies dominate this field: cold atmospheric plasma (CAP) and thermal plasma systems. Cold plasma operates at room temperatures, allowing for non-thermal applications in delicate surgeries like ophthalmology and dermatology. Thermal plasma, on the other hand, produces higher temperatures suitable for coagulation and ablation in areas like orthopedic and ENT procedures. These distinct modalities offer precise tissue targeting without extensive collateral damage, setting plasma systems apart from electrocautery, laser, and radiofrequency alternatives. Unlike traditional energy-based devices, plasma scalpels and ablators deliver a significantly higher degree of surgical precision and reduced thermal spread. For instance, in procedures such as tonsillectomies and adenoidectomies, plasma scalpels have been shown to reduce intraoperative bleeding and postoperative pain. The ability to combine cutting and coagulation in a single step is gaining traction in ENT, neurosurgery, gynecology, and urology. Furthermore, advancements in bipolar plasma technology are enabling real-time modulation of energy delivery based on tissue impedance, further enhancing intraoperative control. Clinical trials continue to highlight improved wound healing, reduced inflammatory response, and faster recovery time-all of which are encouraging broader adoption.

Where Are Plasma Surgery Systems Finding the Greatest Market Penetration?

The clinical adoption of plasma surgical devices is being driven by their compatibility across a wide range of surgical specialties. Otolaryngology (ENT) represents one of the earliest adopters of plasma technology, where procedures such as turbinate reduction, tonsillectomy, and polypectomy leverage the technique’s low-bleed profile. Similarly, in gynecology, plasma-based endometrial ablation and laparoscopic interventions are rising, especially for patients with contraindications to thermal damage. Another high-growth area is orthopedic and spinal surgery, where plasma wands enable efficient removal of soft tissue and precise coagulation around sensitive neural structures. The oncology segment is beginning to explore cold plasma applications for tumor reduction, particularly in superficial cancers like basal cell carcinoma and squamous cell carcinoma. Moreover, in neurosurgery, where surgical accuracy is paramount, cold plasma systems are being trialed to dissect tumors in eloquent brain areas while preserving surrounding tissue integrity. The aesthetic surgery and dermatology sectors are also rapidly integrating plasma pens for skin resurfacing, acne scar treatment, and non-ablative skin rejuvenation-especially in clinics focusing on scarless, outpatient procedures.

Regionally, North America leads the global plasma surgery market due to advanced healthcare infrastructure, high procedural volume, and the presence of prominent players such as Medtronic, Smith & Nephew, and Bovie Medical. Europe follows closely, particularly in Germany and the UK, where ENT and gynecological use cases have been mainstreamed. The Asia-Pacific market, although nascent, is showing strong potential driven by increasing surgical volumes, a growing private hospital base, and rising interest in non-thermal plasma applications in dermatology and oncology. Countries like South Korea and India are emerging as early adopters of portable and handheld plasma devices due to cost constraints and demand for minimally invasive treatments.

How Is Innovation Shaping the Future of Plasma-Based Surgical Technologies?

Technological advancement is a key pillar supporting the expansion of plasma surgery applications. Recent breakthroughs include the miniaturization of plasma devices, enabling their integration into robotic surgical arms and flexible endoscopic platforms. This development is particularly critical for accessing hard-to-reach anatomical areas, including intracranial, bronchial, and gastrointestinal cavities. The coupling of cold plasma systems with fiber-optic delivery modules has allowed for safer, more targeted application of plasma in endoluminal surgeries, such as endobronchial ablation and transnasal interventions. Moreover, research is progressing rapidly on plasma-activated media (PAM), where biological fluids are ionized and then applied to tissue, offering a promising approach for sterilization and cancer cell apoptosis without direct contact. Integration of AI and real-time analytics is also beginning to emerge in next-generation plasma systems. Algorithms that adapt energy output based on tissue feedback are enhancing safety and reducing intraoperative guesswork. On the material science front, the development of biocompatible electrode coatings and high-frequency modulation circuits is enabling greater control over arc formation and power density, essential for expanding indications.

In addition to hardware innovation, software-driven advancements in user interface and procedural templates are making plasma devices more surgeon-friendly. Devices now offer touchscreen controls, pre-programmed procedure modes, and integration with hospital EHRs. These features are streamlining device training, standardizing procedural outcomes, and expanding access in outpatient settings. Meanwhile, cross-industry collaborations between device manufacturers, clinical researchers, and academic institutions are helping to establish more robust clinical protocols and safety benchmarks, facilitating faster regulatory approvals and accelerating market entry in emerging economies.

What Are the Key Market Catalysts Fueling the Rise of Plasma Surgery Worldwide?

The growth in the global plasma surgery market is driven by several factors that span technological, clinical, regulatory, and economic domains. One of the primary growth drivers is the increasing preference for minimally invasive surgical (MIS) techniques across nearly all surgical specialties. Surgeons and healthcare providers are shifting toward low-trauma interventions that reduce hospitalization time, complications, and overall procedural costs-areas where plasma surgery is particularly well-suited. Plasma systems allow for effective hemostasis, enhanced visibility, and shorter recovery times, all of which are critical to accelerating surgical throughput and improving patient satisfaction. Another driver is the ongoing global expansion of outpatient and ambulatory surgical centers (ASCs), especially in the U.S., Japan, and India. These settings demand compact, multifunctional tools with high safety margins-requirements that plasma devices meet effectively. In addition, increasing geriatric populations and rising prevalence of chronic conditions such as cancer, uterine fibroids, nasal polyps, and osteoarthritis are spurring demand for less invasive yet highly effective surgical treatments. Plasma surgery is emerging as a go-to option in such contexts, especially where conventional modalities pose excessive risk or require extended rehabilitation. Market momentum is also supported by more favorable regulatory landscapes and reimbursement frameworks. For instance, certain cold plasma applications in dermatology and ENT surgeries are now covered by public and private insurers in the U.S. and Germany. Furthermore, strategic investments by leading device manufacturers into R&D, product training, and global distributor networks are facilitating deeper market penetration. Collaborations with academic institutions for clinical validation are enabling faster integration of plasma technologies into standard-of-care practices.

Finally, growing awareness of surgical smoke hazards and tissue charring associated with traditional electrosurgery is nudging healthcare systems toward safer alternatives. Plasma devices, known for reduced tissue necrosis and minimal surgical plume, are gaining preference among surgeons concerned with occupational exposure and patient outcomes. As these factors coalesce, the plasma surgery market is poised to become a central player in the next era of precision surgical technologies, with adoption likely to extend far beyond its current strongholds.

SCOPE OF STUDY:

The report analyzes the Plasma Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Neutral Plasma Surgery System, Plasma Ablation System, Cold Plasma Surgical System); Application (Ablation Application, Resection Application, Dissection Application); End-Use (Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Hospitals End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Apyx Medical Corporation
• Bovie Medical Corporation
• CONMED Corporation
• Ethicon (Johnson & Johnson)
• LivaNova plc
• Luxim
• Maquet (Getinge Group)
• Medtronic plc
• Medviatech (Otech/Airplasma)
• Olympus Corporation
• PlasmaJet (Plasma Surgical)
• Plasma Surgical, Inc.
• Renuvion (Apyx)
• Smith & Nephew plc
• Surgnova Healthcare
• US Medical Innovations (USMI)
• Ushio Inc.
• Xenco Medical
• DAMAI Tech Co., Ltd.
• Maquet (Getinge Group)
• CONMED Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Plasma Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Preference for Minimally Invasive Procedures Spurs Growth in Plasma Surgery Market
  • Rising Incidence of Chronic Disorders and Cancer Expands Addressable Market Opportunity
  • Adoption of Cold Plasma Technology Strengthens Business Case for Surgical Applications
  • Growing Use of Plasma Ablation in ENT and Gynecology Accelerates Demand for Specialized Devices
  • Technological Advancements in Plasma-Based Energy Delivery Systems Drive Market Innovation
  • Shift Toward Outpatient and Ambulatory Surgical Centers Propels Demand for Compact Plasma Units
  • Surge in Cosmetic and Dermatological Applications Throws the Spotlight on Plasma-Based Aesthetic Procedures
  • Increasing Focus on Scar-Free Surgeries and Enhanced Healing Drives Adoption of Plasma Modalities
  • Integration of AI and Imaging in Plasma Surgery Tools Enhances Clinical Precision and Boosts Market Growth
  • Regulatory Push for Safety and Efficacy Standards Creates Both Challenges and Opportunities
  • Growing Hospital Investment in High-End Surgical Equipment Generates Opportunities for Plasma Surgery Devices
  • Expanding Geriatric Population Base Spurs Growth in Age-Related Plasma Surgery Procedures
  • Rising Surgical Volume in Emerging Markets Sustains Growth of Affordable Plasma Technologies
  • Industry Collaborations and Strategic Licensing Deals Fuel Innovation in Plasma Surgery Ecosystem
  • Demand for Energy-Based Hemostasis and Coagulation Solutions Drives Adoption of Plasma Technologies
  • Greater Acceptance of Plasma Devices in Oncology and Tumor Resection Strengthens Clinical Value Proposition
  • Increased Medical Education and Surgeon Awareness Initiatives Expand Market Penetration
  • Government Funding and Public-Private Research Partnerships Propel Development of Next-Gen Plasma Tools
  • Competitive Pricing and Reimbursement Dynamics Pose Challenges to Widespread Technology Adoption
  • Convergence of Plasma Surgery with Robotics and Navigation Systems Unlocks Long-Term Growth Potential
  • Environmental and Sterilization Advantages of Plasma Devices Enhance Market Attractiveness
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plasma Surgery Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plasma Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plasma Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Plasma Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Neutral Plasma Surgery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Neutral Plasma Surgery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Neutral Plasma Surgery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Plasma Ablation System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Plasma Ablation System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Plasma Ablation System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cold Plasma Surgical System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cold Plasma Surgical System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Cold Plasma Surgical System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ablation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ablation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Ablation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Resection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Resection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Resection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Dissection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Dissection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Dissection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Plasma Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Plasma Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Plasma Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Plasma Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Plasma Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Plasma Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Plasma Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Plasma Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Plasma Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Plasma Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Plasma Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Plasma Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Plasma Surgery by Product - Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Plasma Surgery by Product - Percentage Breakdown of Value Sales for Neutral Plasma Surgery System, Plasma Ablation System and Cold Plasma Surgical System for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Plasma Surgery by Application - Ablation Application, Resection Application and Dissection Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Plasma Surgery by Application - Percentage Breakdown of Value Sales for Ablation Application, Resection Application and Dissection Application for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Plasma Surgery by End-Use - Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Plasma Surgery by End-Use - Percentage Breakdown of Value Sales for Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Hospitals End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION